Airbus A380 Cracks,...
Health Care: Drugs
Discovery Laboratories Inc. (DSCO: NASDAQ)
$2.65 -0.03 | -1.05%
02/09/12 - 02:13 PM ET
252.15K / 160.40K
Vol / Avg. Vol:2.76 / 2.68
Open / Prev. Close:2.55 - 2.78
Today's Range:1.44 - 3.03
52 Wk Range:59.52%
Performance YTD:TheStreet Rating:
Portfolios with DSCO
- Portfolio NameUser Type
- Userjet189 Portfolio 1
- UserKJP Spring Break
- Uservolume spike
- Usermoon_in_mood Portfolio 1
- UserDtech Portfolio 1
- UserLizann
- UserBNunnally Portfolio 1
- Usershaldar Portfolio 1
- UserAlycia's Speculative Stocks
- UserFATZ 1
Latest DSCO Headlines from TheStreet
- Play TheStreet's FDA Drug-Approval Contest 01.23.12 | 08:01 am
- 27 Hot Drugs Facing FDA Approval in 2012 12.19.11 | 10:12 am
- 22 Hot Drugs Facing FDA Approval in 2012 11.29.11 | 08:11 am
- Biotech Stock Mailbag: Mela Sciences 09.09.11 | 06:09 am
- OXiGene: Small-Cap Winners 05.12.11 | 11:05 am
- Discovery Labs Reports Fourth Quarter Financial Results And Provides An Update On Key Pipeline Programs 03.22.11 | 07:03 am
- Discovery Labs Announces Quarterly Business Update Conference Call 03.10.11 | 08:03 am
- Discovery Labs Announces Completion Of $23.5 Million Public Offering 02.22.11 | 04:02 pm
- Discovery Labs Prices $23.5 Million Public Offering Of Common Stock And Warrants 02.16.11 | 09:02 am
- Discovery Labs Announces Proposed Public Offering Of Common Stock And Warrants 02.15.11 | 04:02 pm
Press Releases for DSCO
- Discovery Labs Signs Manufacturing Agreement For AFECTAIR® - PR Newswire 02.08.12 | 07:02 am
- Discovery Labs Cleared To Market AFECTAIR In U.S. - PR Newswire 02.02.12 | 07:02 am
- New Study Shows AFECTAIR® Significantly Improved Delivery Of Nitric Oxide Under Simulated Neonatal Ventilatory Conditions - PR Newswire 12.06.11 | 08:12 am
- Discovery Labs Releases New AFECTAIR⢠Performance Data Presented At The American Association For Respiratory Care Annual Meeting - PR Newswire 11.08.11 | 08:11 am
- New Study Shows Neonatologists And Parents Of NICU Infants Share Concern Regarding Newborn Exposure To Animal-Derived Medications - PR Newswire 10.18.11 | 07:10 am
- Discovery Labs Notified Of PDUFA Date For SURFAXIN® - PR Newswire 09.28.11 | 12:09 pm
- Discovery Labs Submits SURFAXIN® Complete Response To FDA - PR Newswire 09.06.11 | 07:09 am
Partner Headlines for DSCO
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 11.15.11 | 09:11 am
- UPDATE 1-Discovery Labs' cystic fibrosis drug gets orphan status - Reuters 11.01.10 | 08:11 am
- UPDATE 1-Discovery Labs lung drug disappoints in mid-stage trial - Reuters 06.09.10 | 08:06 am
- FDA, Clinical Trial News: Discovery Labs, Hospira, Javelin Pharma - Seeking Alpha 05.20.10 | 06:05 am
- UPDATE 2-Discovery Labs inches closer to lung drug approval - Reuters 05.19.10 | 10:05 am
- Discovery Labs: Small Biotech With Multiple Prime Time Catalysts - Seeking Alpha 05.11.10 | 05:05 am
- UPDATE 1-Discovery: Only animal trials needed for lung drug OK - Reuters 02.16.10 | 08:02 am
